NCBI Logo
GEO Logo
   NCBI > GEO > Accession DisplayHelp Not logged in | LoginHelp
GEO help: Mouse over screen elements for information.
          Go
Series GSE43407 Query DataSets for GSE43407
Status Public on Jan 11, 2013
Title Dosage dependent tumor suppression by histone deacetylase 1 and 2 by regulation of Myc collaborating genes and p53 function
Organism Mus musculus
Experiment type Genome variation profiling by genome tiling array
Summary comparative genome hybridisation of Hdac1/2 cKO lymphomas and matched normal tissue
Histone deacetylases (HDACs) are epigenetic erasers of lysine-acetyl marks. Inhibition of HDACs using small molecule inhibitors (HDACi) is a potential strategy in the treatment of various diseases and is approved for treating hematological malignancies. Harnessing the therapeutic potential of HDACi requires knowledge of HDAC-function in vivo. Here, we generated a thymocyte-specific gradient of HDAC-activity using compound conditional knockout mice for Hdac1 and Hdac2. Unexpectedly, gradual loss of HDAC-activity engendered a dosage dependent accumulation of immature thymocytes and correlated with the incidence and latency of monoclonal lymphoblastic thymic lymphomas. Strikingly, complete ablation of Hdac1 and Hdac2 abrogated lymphomagenesis due to a block in early thymic development. Genomic, biochemical and functional analyses of pre-leukemic thymocytes and tumors revealed a critical role for Hdac1/Hdac2-governed HDAC-activity in regulating a p53-dependent barrier to constrain Myc-overexpressing thymocytes from progressing into lymphomas by regulating Myc-collaborating genes. One Myc-collaborating and p53-suppressing gene, Jdp2, was derepressed in an Hdac1/2-dependent manner and critical for the survival of Jdp2-overexpressing lymphoma cells. Although reduced HDAC-activity facilitates oncogenic transformation in normal cells, resulting tumor cells remain highly dependent on HDAC-activity, indicating that a critical level of Hdac1 and Hdac2 governed HDAC-activity is required for tumor maintenance.
 
Overall design genomic DNA from LckCre+;Hdac1/2 cKO lymphomas and matched normal genomic DNA was hybridized onto a Nimblegen whole genome array
 
Contributor(s) Heideman MR, Wilting RH, Yanover E, Velds A, de Jong J, Kerkhoven RM, Jacobs H, Wessels LF, Dannenberg J
Citation(s) 23327920
Submission date Jan 10, 2013
Last update date Apr 05, 2013
Contact name Jan-Hermen Dannenberg
E-mail(s) j.dannenberg@nki.nl
Organization name Antoni van Leeuwenhoek hospital
Street address Plesmanlaan 121
City Amsterdam
State/province N-Holland
ZIP/Postal code 1066 CX
Country Netherlands
 
Platforms (1)
GPL13924 Nimblegen 12-plex 135K full genome mouse custom NKI array [091016_MM9_RK_CGH_HX12]
Samples (6)
GSM1062189 LckCre+;Hdac1L/L [470365A01]
GSM1062190 LckCre+;Hdac1L/+;Hdac2L/L [470365A03]
GSM1062191 LckCre+;Hdac1L/L;Hdac2L/+ [425030A06]
Relations
BioProject PRJNA185991

Download family Format
SOFT formatted family file(s) SOFTHelp
MINiML formatted family file(s) MINiMLHelp
Series Matrix File(s) TXTHelp

Supplementary file Size Download File type/resource
GSE43407_RAW.tar 74.5 Mb (http)(custom) TAR (of PAIR, TXT)
Processed data included within Sample table
Processed data provided as supplementary file

| NLM | NIH | GEO Help | Disclaimer | Accessibility |
NCBI Home NCBI Search NCBI SiteMap